Propaten Randomized Investigation on Cost-benefit and Efficacy
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 103 participants.
Also called NCT01601873
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 103 participants
- Sponsor
- Registry
-
NCT01601873
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT01601873. Randomized; double masking; primary purpose treatment. Start 2012-11-09 (actual); primary completion 2017-12-31 (actual). Results posted on 2019-02-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Propaten Randomized Investigation on Cost-benefit and Efficacy
- Acronym
- PRICE
- Condition
- End-stage Renal Disease
- Intervention (Device)
- PROPATEN
- Intervention (Device)
- Standard Graft
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Collaborator
- University Hospitals Cleveland Medical Center
- Collaborator
- University of Arkansas
- Collaborator
- Ochsner Health System
Record details
- Record id
cardio:ct-nct01601873- Content hash
8a86a3967ab0de38f2887a83929d660558515e75c399b528cbbdf480c37f735b